Clinical-stage biotech company Rhythm Pharmaceuticals, backed by France-based pharmaceutical company Ipsen, has filed to raise up to $86m in an IPO.

Lending Club, an online market place for loans which is backed by Google Ventures, is seeking to raise $500m from its IPO.

The Parkinson's disease drug developer has filed for an initial public offering the day after closing a $55m Alkermes-backed series C round.

The Google and Salesforce-backed sales and marketing software company has raised about $100m in venture funding so far.

The Nippon Insurance and Recruit-backed task crowdsourcing platform has been approved for an IPO in Japan.

Otonomy, which is developing treatments for ear disorders, could boost the size of the offering to $115m if the underwriters take up the option to buy more shares.

The pharmaceutical company has raised over $100m in equity funding from investors including Boehringer Ingelheim and Allergen.

The Novartis-backed prostate cancer drug developer has filed for an initial public offering after raising more than $100m in funding.

Tencent invested $60m to become IDreamSky's largest shareholder as the mobile game publisher went public priced above its range.

The eye disease drug developer raised $102m in an upsized initial public offering as pharmaceutical company Regeneron invested a further $10m.